TLR4 Modulating Compounds for Specific Immune Response Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for modulating innate immune responses, particularly through Toll-like receptors (TLRs), face limitations in effectively activating or inhibiting specific immune responses and managing inflammation, with existing compounds often lacking specificity and efficacy.
Innovation Solution
Development of pharmaceutical compositions and vaccines containing specific compounds with the formula, which act as TLR modulators, specifically interacting with Toll-like receptor 4 (TLR4) to modulate immune responses and reduce inflammation by administering effective amounts of these compounds to subjects in need.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing compounds are used to modulate TLR4, then immune response modulation is achieved, but specificity and efficacy are insufficient
Solution Approach 1:
The patent applies parameter changes by systematically modifying molecular parameters of TLR4 modulator compounds, including substituent groups (R1-R4), ring sizes (z1-z2), and chemical structures to optimize both specificity for TLR4 and efficacy in activating or inhibiting immune responses. This involves changing chemical parameters to achieve desired biological effects while maintaining or improving specificity.
2Reliability
If compounds are designed for high specificity to TLR4, then efficacy in modulating immune response improves, but complexity of compound structure increases
Solution Approach 1:
The patent applies local quality by identifying and optimizing specific local regions of the compound structure that interact with TLR4, such as particular substituent positions (R1-R4) and ring structures (z1-z2). By focusing optimization on these local structural elements rather than redesigning the entire molecule, the patent achieves high specificity while controlling overall structural complexity.
3Object-affected harmful factors
If compounds are administered to modulate immune response, then inflammation reduction is achieved, but safety and bioavailability must be maintained
Solution Approach 1:
The patent applies parameter changes by optimizing pharmacokinetic parameters of the compounds, including solubility, stability, and metabolic resistance, to ensure safe administration and adequate bioavailability. This involves adjusting chemical parameters such as functional groups and molecular properties to achieve desired therapeutic effects while maintaining safety profiles.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compounds effectively activate or inhibit TLR4, leading to precise modulation of immune responses and reduction of inflammation, as demonstrated by significant activation of NF-κB pathways and cytokine production, while maintaining safety and bioavailability.
Implementation Method 1
The Toll-like receptors (TLRs) are critical components of the innate immune system that regulate NFκB activation. In general, the TLRs recognize macromolecules that are associated with pathogens and with cell stress.
Implementation Method 2
The compounds effectively activate or inhibit TLR4, leading to precise modulation of immune responses and reduction of inflammation, as demonstrated by significant activation of NF-κB pathways and cytokine production
Data Source
AI summary
Provided herein, inter alia, are methods and compositions for modulating TLR-4.